Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$913M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$818M |
| 3 |
Microsoft
MSFT
|
+$369M |
| 4 |
MongoDB
MDB
|
+$345M |
| 5 |
Grab
GRAB
|
+$339M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$867M |
| 2 |
PayPal
PYPL
|
+$519M |
| 3 |
Alibaba
BABA
|
+$393M |
| 4 |
CrowdStrike
CRWD
|
+$360M |
| 5 |
DOCU
DocuSign
DOCU
|
+$335M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.56% |
| 2 | Healthcare | 12.66% |
| 3 | Financials | 12.55% |
| 4 | Consumer Discretionary | 11.59% |
| 5 | Industrials | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMTI
3751
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
| $143K | ﹤0.01% |
10,230
-1,082
| -10% | -$21.3K |
|
3752
Cue Biopharma
CUE
$110M
| $142K | ﹤0.01% |
419
-6
| -1% | -$2.32K |
|
|
RDUS
3753
DELISTED
Radius Health, Inc.
RDUS
| $142K | ﹤0.01% |
20,611
-1,542
| -7% | -$22.6K |
|
3754
Lifestance Health
LFST
$4.55B
| $141K | ﹤0.01% |
14,853
-680
| -4% | -$7.21K |
|
3755
Payoneer
PAYO
$2.4B
| $140K | ﹤0.01% |
18,967
-2,829,304
| -99% | -$21.7M |
|
|
USAP
3756
DELISTED
Universal Stainless & Alloy
USAP
| $139K | ﹤0.01% |
17,453
-1,132
| -6% | -$10.1K |
|
3757
Apyx Medical
APYX
$146M
| $138K | ﹤0.01% |
10,768
-4,406
| -29% | -$61.6K |
|
|
ZEPP
3758
Zepp Health
ZEPP
$76.1M
| $138K | ﹤0.01% |
6,824
+627
| +10% | +$18.8K |
|
|
AERI
3759
DELISTED
Aerie Pharmaceuticals
AERI
| $137K | ﹤0.01% |
19,418
-1,639
| -8% | -$17.1K |
|
3760
Dyne Therapeutics
DYN
$4.95B
| $136K | ﹤0.01% |
11,406
-135
| -1% | -$1.9K |
|
|
GBIO
3761
DELISTED
Generation Bio
GBIO
| $135K | ﹤0.01% |
1,895
-181
| -9% | -$31.6K |
|
3762
Geron
GERN
$949M
| $134K | ﹤0.01% |
109,406
-17,742
| -14% | -$25.4K |
|
3763
Pliant Therapeutics
PLRX
$64.4M
| $134K | ﹤0.01% |
10,011
-1,190
| -11% | -$18.9K |
|
|
CLVS
3764
DELISTED
Clovis Oncology, Inc.
CLVS
| $134K | ﹤0.01% |
49,243
-1,572
| -3% | -$5.81K |
|
3765
Kiniksa Pharmaceuticals
KNSA
$5.97B
| $133K | ﹤0.01% |
11,240
-1,496
| -12% | -$18.4K |
|
|
CANO
3766
DELISTED
Cano Health, Inc.
CANO
| $133K | ﹤0.01% |
+150
| New | +$158K |
|
|
CNTB
3767
Connect Biopharma Holdings
CNTB
$135M
| $132K | ﹤0.01% |
25,629
+16,570
| +183% | +$184K |
|
|
GAN
3768
DELISTED
GAN Ltd
GAN
| $131K | ﹤0.01% |
14,301
-1,119
| -7% | -$13.7K |
|
3769
Reading International Class A
RDI
$35.2M
| $131K | ﹤0.01% |
32,360
-2,097
| -6% | -$9.76K |
|
|
WIMI
3770
WiMi Hologram Cloud
WIMI
$24.8M
| $131K | ﹤0.01% |
4,309
+397
| +10% | +$16K |
|
|
RAAS
3771
DELISTED
Cloopen Group Holding Limited American Depositary Shares (each representing six (6) Class A Ordinary Shares)
RAAS
| $130K | ﹤0.01% |
+14,919
| New | +$169K |
|
3772
Annexon
ANNX
$883M
| $128K | ﹤0.01% |
11,161
-1,843
| -14% | -$29.8K |
|
3773
Verastem
VSTM
$615M
| $128K | ﹤0.01% |
5,211
-474
| -8% | -$15K |
|
|
BDSI
3774
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $128K | ﹤0.01% |
41,029
-3,481
| -8% | -$11.7K |
|
3775
VistaGen Therapeutics
VTGN
$11.7M
| $127K | ﹤0.01% |
2,165
-1,602
| -43% | -$104K |
|
Similar funds
Invesco's Q4 2021 Portfolio in Review
As of Q4 2021, Invesco held 4,196 positions worth $415B, up 5.1% from $395B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Invesco's Q4 2021 filing shows 190 new, 1,645 increased, 2,044 reduced and 170 closed positions. Its largest new stake was Grab: 44,484,753 shares worth $317M. The largest sale was Meta Platforms (Facebook), an estimated $867M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- Invesco's largest Q4 2021 buy was Grab: 44,484,753 shares worth $317M.
- Invesco added most to Apple in Q4 2021, an estimated $913M increase.
- Invesco's biggest Q4 2021 reduction was Meta Platforms (Facebook), cutting an estimated $867M.
- Invesco fully exited Kansas City Southern in Q4 2021, selling an estimated $110M.
- Invesco's ten largest holdings make up 12% of its $415B portfolio in Q4 2021.
- Invesco opened 190 new positions and closed 170 in Q4 2021.
- Invesco's portfolio value rose 5.1% quarter-over-quarter to $415B.
Based on Invesco's 13F filing for Q4 2021, filed 14 Feb 2022.